OCX OncoCyte Corp.

2.09-0.03 (-1.41%)
15 minute delayed price: 12:22:35 PM

Quote

Previous Close
$2.12
Day Range
$2.09-$2.15
52 Week Range
$1.16-$6.92
Volume
46,475
Avg Volume
530,870
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$108.62M
Enterprise Value (EV)
$103.44M
PE Ratio
-
EV/EBITDA
-7.38
Price/Sales
-
Price/Book
32.19
PEG Ratio
0.17

Financials

Revenue
-
Gross Profit
-$559.00K
EBITDA
-$14.02M
EPS, ttm
-$0.38
Profit Margin
-
Revenue/Employee
-
Next Earnings Date
8/13/2019 (26 days)
Debt to Equity
50%
Debt
$3.28M
Cash
$8.46M
Net Debt
-

Performance

Beta
0.69
200 Day Moving Avg
$3.00
50 Day Moving Avg
$3.62
52 Week Change
-29.33%
YTD Change
42.80%
1 Month Change
-42.86%
3 Month Change
-48.92%
6 Month Change
17.78%
1 Year Change
-29.33%
2 Year Change
-25.21%
5 Year Change
-44.93%

Share Count

Shares Outstanding
52.0M
Float
-
Restricted Shares
52.0M
Restricted Shares, %
100.00%

OncoCyte Corp. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Ronald Asbury Andrews

Website: http://www.oncocyte.com

Description: OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.

Employees: 12